<DOC>
	<DOCNO>NCT02439424</DOCNO>
	<brief_summary>Recent advancement implantable cardiac device technology include extensive diagnostic therapeutic algorithm prevention well termination atrial tachyarrhythmias ( ATA ) . Preventive atrial pacing ( PAP ) novel atrial antitachycardia pace algorithm ( Reactive ATP™ ) conjunction manage ventricular pacing ( MVP ) recently show reduce progression permanent atrial fibrillation ( AF ) pacemaker patient intact atriovenous ( AV ) conduction history ATA . Whether use Reactive ATP™ reduce AF burden extend patient implantable cardioverter defibrillator ( ICD ) , typically structural heart disease heart hailure ( HF ) , unknown .</brief_summary>
	<brief_title>The REACT-ICD Trial</brief_title>
	<detailed_description>Atrial tachyarrhythmias ( ATA ) heart failure ( HF ) , well-recognized cause morbidity mortality , grow concern issue patient population . In patient implanted dual-chamber implantable cardioverter defibrillator ( ICD ) , progression paroxysmal persistent permanent atrial fibrillation ( AF ) document . Because untoward consequence AF , development/worsening HF thromboembolic event ( stroke myocardial infarction [ MI ] ) , prevention permanent AF potential improve quality life , reduce hospitalization , decrease complication associate AF . Recent advancement implantable cardiac device technology include extensive diagnostic therapeutic algorithm prevention well termination ATA . Preventive atrial pacing ( PAP ) novel atrial antitachycardia pace algorithm ( Reactive ATP™ ) conjunction manage ventricular pacing ( MVP ) recently show reduce progression permanent AF pacemaker patient intact atriovenous ( AV ) conduction history ATA . Results study suggest Reactive ATP™ specifically responsible effect . Whether use Reactive ATP™ reduce AF burden extend patient implantable cardioverter defibrillator ( ICD ) , typically structural heart disease HF , unknown . The aim study evaluate effectiveness atrial antitachycardia pacing ( Reactive ATP ) patient implant either dual-chamber cardiac resynchronization therapy ( CRT ) ICD history ATA .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>male female patient ≥18 year old ( upper age limit ) previously implant Medtronic dualchamber CRT ICD capability atrial antitachycardia pacing ; specifically , Reactive ATP™ least 9 month previously ( six month data collection implant occur least 3 month previously allow heal establishment stable sensing ) measure P wave sinus rhythm least 0.8 mV &gt; =6 month AT/AF burden data available , either CareLink® inoffice interrogation &gt; =1.0 % AT/AF burden ( hour atrial fibrillation/total hour monitor ) last 6 month No change antiarrhythmic drug therapy ( VaughanWilliams class I III ) last 6 month Persistent permanent AT/AF ( AF burden &gt; 95 % ) Cardioversion atrial fibrillation atrial flutter within last 6 month , either intentional result tachyarrhythmia therapy Ablation atrial fibrillation atrial flutter within last 9 month ( 6 month data collection follow 3 month blank period post procedure ) Reactive ATP™ previously program Measured P wave sinus rhythm consistently &lt; 0.8 mV repeat measurement . Unresolved artifactual AT/AF detection due farfield R wave oversensing Expected generator change device surgery within six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>